Andere Sprachen Kyowa Kirin Co. Ltd.

Aktien

858523

JP3256000005

4151

Markt geschlossen - Japan Exchange Andere Börsenplätze 08:00:00 10.05.2024			% 5 Tage	% 1. Jan.
2.670 ^JPY	+0,95 %		+0,07 %	+12,64 %

07.05.	Gewinn von Kyowa Kirin steigt in Q1 um 15%	MT
02.05.	BridgeBio Pharma-Aktien geben nach Q1-Finanzergebnissen nach	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Kyowa Kirin : Transcript of Results Briefing Fiscal 2024 First Quarter (0B)	09.05.
Kyowa Kirin's Profit Up 15% in Q1	07.05.
Kyowa Kirin : Results Presentation Fiscal 2024 First Quarter (0B)	07.05.
Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024 TIME100 Health List	06.05.
Kyowa Kirin Buys Back Shares for 5.6 Billion Yen in April	06.05.
BridgeBio Pharma Shares Decline After Q1 Financial Results	02.05.
Kyowa Kirin to Present a Safety Meta-Analysis of NOURIANZ (istradefylline) and Other Parkinson's Disease Add-On Therapies	15.04.
First Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary Syndrome	15.04.
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease	08.04.
Kyowa Kirin Buys Back 4 Billion Yen Worth of Shares in March	03.04.
Tranche Update on Kyowa Kirin Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024.	02.04.
Japanese Shares Slip into Red Amid Profit-Taking; Tokyo Inflation Eyed	25.03.
Kyowa Kirin to Allocate Over 84,000 Treasury Shares as Director, Officer Compensation	25.03.
Kyowa Kirin's gene therapy most expensive US drug with $4.3 million price tag	20.03.
EEUU aprueba la primera terapia de genes para niños con una rara enfermedad hereditaria	18.03.
US approves first gene therapy for children with rare genetic disease	18.03.
US approves first gene therapy for rare genetic disease	18.03.
Kyowa Kirin Will Present Phase 2b Post-hoc Analysis and Symposium at the American Academy of Dermatology Annual Meeting 2024	11.03.
Kyowa Kirin Co., Ltd. to Present Phase 2B Post-Hoc Analysis and Symposium At the American Academy of Dermatology Annual Meeting 2024	08.03.
Kyowa Kirin : Partial Corrections to “Notice of Convocation of the 101st Ordinary General Meeting of Shareholders” (0B)	06.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Kyowa Kirin Co. Ltd.

Aktien

858523

JP3256000005

4151

Andere Sprachen

Filter